NF-kB p65 (RELA) Rabbit Polyclonal Antibody
CNY 1999.00
CNY 2700.00
| Cited in 3 publications. | 
CNY 4840.00
                                                
                                                
                                                
                                                    CNY 300.00 
                                                    
                                                    CNY 1430.00
                                                
                                            
CNY 2900.00
CNY 9998.00
Specifications
| Product Data | |
| Applications | IHC, WB | 
| Recommend Dilution | WB 1:2000, IHC 1:150 | 
| Reactivity | Human, Mouse, Rat | 
| Host | Rabbit | 
| Clonality | Polyclonal | 
| Immunogen | Synthetic peptide conjugated to KLH derived from within residues 100 - 170 of Human RELA. | 
| Isotype | IgG | 
| Formulation | PBS (pH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide. | 
| Concentration | 1 mg/ml | 
| Purification | Purified from the immunized serum by affinity chromatography (Protein A/G) | 
| Conjugation | Unconjugated | 
| Storage Condition | Store at -20°C as received. | 
| Predicted Protein Size | 60 kDa | 
| Gene Name | RELA proto-oncogene, NF-kB subunit | 
| Database Link | |
| Background | NF-kappa-B is a ubiquitous transcription factor involved in several biological processes. It is held in the cytoplasm in an inactive state by specific inhibitors. Upon degradation of the inhibitor, NF-kappa-B moves to the nucleus and activates transcription of specific genes. NF-kappa-B is composed of NFKB1 or NFKB2 bound to either REL, RELA, or RELB. The most abundant form of NF-kappa-B is NFKB1 complexed with the product of this gene, RELA. Four transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2011] | 
| Synonyms | NFKB3; p65 | 
| Reference Data | |
| Protein Families | Druggable Genome, Transcription Factors | 
| Protein Pathways | Acute myeloid leukemia, Adipocytokine signaling pathway, Apoptosis, B cell receptor signaling pathway, Chemokine signaling pathway, Chronic myeloid leukemia, Cytosolic DNA-sensing pathway, Epithelial cell signaling in Helicobacter pylori infection, MAPK signaling pathway, Neurotrophin signaling pathway, NOD-like receptor signaling pathway, Pancreatic cancer, Pathways in cancer, Prostate cancer, RIG-I-like receptor signaling pathway, Small cell lung cancer, T cell receptor signaling pathway, Toll-like receptor signaling pathway | 
Citations (3)
| The use of this Antibodies has been cited in the following citations: | 
|---|
| Influence of hyperocclusion on the remodeling of gingival tissues
                                                ,Li, Y;Wang, Z;Liu, Y;Zhang, H;Huang, Y;Gao, P;Hu, Y;Xu, Q;,
                                                International immunopharmacology
                                                ,PubMed ID 34153669
                                                [RELA] | 
| Upstream transcription factor 1 prompts malignancies of cervical cancer primarily by transcriptionally activating p65 expression
                                                ,null,
                                                Experimental and Therapeutic Medicine
                                                ,PubMed ID 30542391
                                                [RELA] | 
| The Effects of Interleukin-17 (IL-17)-Related Inflammatory Cytokines and A20 Regulatory Proteins on Astrocytes in Spinal Cord Cultured In Vitro
                                                ,Zong, S;Li, K;Zeng, G;Fang, Y;Zhao, J;,
                                                Cell. Physiol. Biochem.
                                                ,PubMed ID 26938714
                                                [RELA] | 
Documents
| Product Manuals | 
| FAQs | 
| SDS | 
Resources
| 抗体相关资料 | 
其它NF-kB p65产品


 
                         
                             
                             
                             
                             
                             
                             
                             
                            
 
        